Type 1 diabetes

Get ahead of the disease: Islet cell autoimmunity and preclinical phase of type 1 diabetes in general population of 1–9 year‐old children in the north‐eastern region of Poland —A summary of the first 18 months of the study

Diabetes Obes MetabPublished Population-based screening study

Authors' conclusion

Results confirm the importance of screening for IAbs in general paediatric population as a method of prediction of T1D development. The study also shows that patients with a single positive islet autoantibody may have already developed dysglycaemia and therefore need monitoring.

Study context

Population
Children aged 1–9 years from the general population of North-Eastern Poland
Participants
3,575 children
Outcome
Islet autoimmunity and presymptomatic T1D
Methodological detailsgeneral population, stepwise autoantibody screening
  • General population
  • Stepwise autoantibody screening

Main finding

As reported in the abstract

Islet cell autoimmunity

Confirmed islet cell autoimmunity

7.78%

Multiple positive islet autoantibodies (IAbs) (of total)

1.17%

Observational data: associations, not effects.

Further findings

Individual autoantibodies

IAAs most frequent
50.75%
IA-2As least frequent
8.4%
IAAs more frequent with T1D family history
P = 0.04
IAAs more frequent in children aged 1-3 years
P = 0.02
IA2-As frequency increased with age
P = 0.035
ZnT8As frequency increased with age
P = 0.02
ZnT8As more frequent in females
P = 0.024
Multiple positive IAbs almost 2.5-times higher with T1D family history than peers

Follow-up

Children in follow-up
113
Single autoantibody among those with dysglycaemia
almost 67%
Stage 3 diabetes, both diagnosed before DKA
2 (1.77%)

Original publication

Get ahead of the disease: Islet cell autoimmunity and preclinical phase of type 1 diabetes in general population of 1–9 year‐old children in the north‐eastern region of Poland —A summary of the first 18 months of the study. Diabetes Obes Metab. Published 24 June 2025. doi:10.1111/dom.16560

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.